Vladimir Ermolayev1,2, Xose Luis Dean-Ben1, Subhamoy Mandal1, Vasilis Ntziachristos1,2, Daniel Razansky3,4. 1. Institute for Biological and Medical Imaging (IBMI), Helmholtz Center Munich, Ingolstädter Landstraβe 1, 85764, Neuherberg, Germany. 2. Faculty of Medicine, Technical University of Munich, Ismaninger Straβe 22, 81675, Munich, Germany. 3. Institute for Biological and Medical Imaging (IBMI), Helmholtz Center Munich, Ingolstädter Landstraβe 1, 85764, Neuherberg, Germany. dr@tum.de. 4. Faculty of Medicine, Technical University of Munich, Ismaninger Straβe 22, 81675, Munich, Germany. dr@tum.de.
Abstract
OBJECTIVES: Intravital imaging within heterogenic solid tumours is important for understanding blood perfusion profiles responsible for establishment of multiple parameters within the tumour mass, such as hypoxic and nutrition gradients, cell viability, proliferation and drug response potentials. METHODS: Herein, we developed a method based on a volumetric multispectral optoacoustic tomography (vMSOT) for cancer imaging in preclinical models and explored its capacity for three-dimensional imaging of anatomic, vascular and functional tumour profiles in real time. RESULTS: In contrast to methods based on cross-sectional (2D) image acquisition as a basis for 3D rendering, vMSOT has attained concurrent observations from the entire tumour volume at 10 volumetric frames per second. This truly four dimensional imaging performance has enabled here the simultaneous assessment of blood oxygenation gradients and vascularization in solid breast tumours and revealed different types of blood perfusion profiles in-vivo. CONCLUSION: The newly introduced capacity for high-resolution three-dimensional tracking of fast tumour perfusion suggests vMSOT as a powerful method in preclinical cancer research and theranostics. As the imaging setup can be equally operated in both stationary and handheld mode, the solution is readily translatable for perfusion monitoring in a clinical setting. KEY POINTS: • vMSOT visualizes 3D anatomic, vascular and functional tumour profiles in real time. • Three types of blood perfusion profiles are revealed in breast tumour model. • The method is readily adaptable to operate in a handheld clinical mode.
OBJECTIVES: Intravital imaging within heterogenic solid tumours is important for understanding blood perfusion profiles responsible for establishment of multiple parameters within the tumour mass, such as hypoxic and nutrition gradients, cell viability, proliferation and drug response potentials. METHODS: Herein, we developed a method based on a volumetric multispectral optoacoustic tomography (vMSOT) for cancer imaging in preclinical models and explored its capacity for three-dimensional imaging of anatomic, vascular and functional tumour profiles in real time. RESULTS: In contrast to methods based on cross-sectional (2D) image acquisition as a basis for 3D rendering, vMSOT has attained concurrent observations from the entire tumour volume at 10 volumetric frames per second. This truly four dimensional imaging performance has enabled here the simultaneous assessment of blood oxygenation gradients and vascularization in solid breast tumours and revealed different types of blood perfusion profiles in-vivo. CONCLUSION: The newly introduced capacity for high-resolution three-dimensional tracking of fast tumour perfusion suggests vMSOT as a powerful method in preclinical cancer research and theranostics. As the imaging setup can be equally operated in both stationary and handheld mode, the solution is readily translatable for perfusion monitoring in a clinical setting. KEY POINTS: • vMSOT visualizes 3D anatomic, vascular and functional tumour profiles in real time. • Three types of blood perfusion profiles are revealed in breast tumour model. • The method is readily adaptable to operate in a handheld clinical mode.
Entities:
Keywords:
3D Optoacoustic tomography; Breast cancer; Molecular imaging; Nanoparticles; Neovascularization
Authors: Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos Journal: Nat Methods Date: 2012-05-06 Impact factor: 28.547
Authors: Jun Xia; Muhammad R Chatni; Konstantin Maslov; Zijian Guo; Kun Wang; Mark Anastasio; Lihong V Wang Journal: J Biomed Opt Date: 2012-05 Impact factor: 3.170
Authors: Jan Laufer; Peter Johnson; Edward Zhang; Bradley Treeby; Ben Cox; Barbara Pedley; Paul Beard Journal: J Biomed Opt Date: 2012-05 Impact factor: 3.170
Authors: Daniel Razansky; Niels J Harlaar; Jan Luuk Hillebrands; Adrian Taruttis; Eva Herzog; Clark J Zeebregts; Gooitzen M van Dam; Vasilis Ntziachristos Journal: Mol Imaging Biol Date: 2012-06 Impact factor: 3.488
Authors: Dominique Van de Sompel; Laura Sarah Sasportas; Anca Dragulescu-Andrasi; Sarah Bohndiek; Sanjiv Sam Gambhir Journal: PLoS One Date: 2012-10-11 Impact factor: 3.240
Authors: Lu Ding; Xose Luis Dean-Ben; Neal C Burton; Robert W Sobol; Vasilis Ntziachristos; Daniel Razansky Journal: IEEE Trans Med Imaging Date: 2017-03-22 Impact factor: 10.048
Authors: Lauren Scarfe; Nathalie Brillant; J Dinesh Kumar; Noura Ali; Ahmed Alrumayh; Mohammed Amali; Stephane Barbellion; Vendula Jones; Marije Niemeijer; Sophie Potdevin; Gautier Roussignol; Anatoly Vaganov; Ivana Barbaric; Michael Barrow; Neal C Burton; John Connell; Francesco Dazzi; Josefina Edsbagge; Neil S French; Julie Holder; Claire Hutchinson; David R Jones; Tammy Kalber; Cerys Lovatt; Mark F Lythgoe; Sara Patel; P Stephen Patrick; Jacqueline Piner; Jens Reinhardt; Emanuelle Ricci; James Sidaway; Glyn N Stacey; Philip J Starkey Lewis; Gareth Sullivan; Arthur Taylor; Bettina Wilm; Harish Poptani; Patricia Murray; Chris E P Goldring; B Kevin Park Journal: NPJ Regen Med Date: 2017-10-19
Authors: Edyta Swider; Khalid Daoudi; Alexander H J Staal; Olga Koshkina; N Koen van Riessen; Eric van Dinther; I Jolanda M de Vries; Chris L de Korte; Mangala Srinivas Journal: Nanotheranostics Date: 2018-06-01